Stopping oxytocin mid-labor shortens the process and reduces C-sections

Article

Despite its widespread use throughout the labor process, no advantage exists to continuing oxytocin infusion after the onset of active labor, according to a small trial of 104 women in Israel. Researchers found that stopping oxytocin at 5 cm dilation, instead of continuing it until delivery, shortened labor, though not significantly so, and halved the number of cesarean sections required.

The researchers admit that the study was underpowered and that the findings could be the result of chance, but their results also support the hypothesis that continuing oxytocin once the active phase of labor has begun actually complicates labor by desensitizing uterine receptors to exogenous and endogenous oxytocin.

Daniel-Spiegel E, Weiner Z, Ben-Shlomo I, et al. For how long should oxytocin be continued during induction of labour? BJOG. 2004;111:331-334.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.